El-Masry, R.M.; Essa, B.M.; Selim, A.A.; El-Emam, S.Z.; Mohamed, K.O.; Sakr, T.M.; Kadry, H.H.; Taher, A.T.; Abou-Seri, S.M.
New 5-Aryl-1,3,4-Thiadiazole-Based Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation and In Vivo Radioactive Tracing Studies. Pharmaceuticals 2022, 15, 1476.
https://doi.org/10.3390/ph15121476
AMA Style
El-Masry RM, Essa BM, Selim AA, El-Emam SZ, Mohamed KO, Sakr TM, Kadry HH, Taher AT, Abou-Seri SM.
New 5-Aryl-1,3,4-Thiadiazole-Based Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation and In Vivo Radioactive Tracing Studies. Pharmaceuticals. 2022; 15(12):1476.
https://doi.org/10.3390/ph15121476
Chicago/Turabian Style
El-Masry, Rana M., Basma M. Essa, Adli A. Selim, Soad Z. El-Emam, Khaled O. Mohamed, Tamer M. Sakr, Hanan H. Kadry, Azza T. Taher, and Sahar M. Abou-Seri.
2022. "New 5-Aryl-1,3,4-Thiadiazole-Based Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation and In Vivo Radioactive Tracing Studies" Pharmaceuticals 15, no. 12: 1476.
https://doi.org/10.3390/ph15121476
APA Style
El-Masry, R. M., Essa, B. M., Selim, A. A., El-Emam, S. Z., Mohamed, K. O., Sakr, T. M., Kadry, H. H., Taher, A. T., & Abou-Seri, S. M.
(2022). New 5-Aryl-1,3,4-Thiadiazole-Based Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation and In Vivo Radioactive Tracing Studies. Pharmaceuticals, 15(12), 1476.
https://doi.org/10.3390/ph15121476
